Unpacking the EU Biotech Act - On Tech Ethics

Discusses the EU Biotech Act, which is a legislative proposal focused on health biotechnology, streamlining clinical trials, and boosting biomanufacturing. 
 
Our guest today is Eline D’Joos who is a life sciences associate in Crowell & Moring’s Brussels office. Her practice focuses on regulatory issues and commercial transactions in the life science sector, as well as interplays with general intellectual property and data protection questions. 
 

Additional resources: 

• EU Biotech Act: https://health.ec.europa.eu/publications/proposal-regulation-establish-measures-strengthen-unions-biotechnology-and-biomanufacturing-sectors_en  
• Crowell & Moring Insights on the EU Biotech Act: https://www.crowell.com/en/insights/client-alerts/european-commission-proposes-biotech-act-to-boost-health-biotechnology-in-the-eu 
• CITI Program’s Tech Ethics solution: https://about.citiprogram.org/solutions/tech-ethics/